119 related articles for article (PubMed ID: 32203934)
21. Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy.
Klepsch V; Hermann-Kleiter N; Baier G
Immunol Lett; 2016 Oct; 178():31-6. PubMed ID: 26992368
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
23. Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma.
Pang JS; Wen DY; He RQ; Chen G; Lin P; Li JH; Zhao YJ; Wu LY; Chen JH; He Y; Qin LT; Chen JB; Li Y; Yang H
Bioengineered; 2021 Dec; 12(1):4289-4303. PubMed ID: 34304715
[TBL] [Abstract][Full Text] [Related]
24. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
25. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
26. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
[TBL] [Abstract][Full Text] [Related]
27. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
[TBL] [Abstract][Full Text] [Related]
28. Nimotuzumab increases chemosensitivity of human lung adenocarcinoma cell lines to docetaxel.
Song HZ; Yi J; Chen J; Chen LB
Oncol Res; 2012; 20(1):39-47. PubMed ID: 23035364
[TBL] [Abstract][Full Text] [Related]
29. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer.
Lin F; Wen D; Wang X; Mahato RI
Biomaterials; 2019 Feb; 192():95-108. PubMed ID: 30447399
[TBL] [Abstract][Full Text] [Related]
30. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
31. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
[TBL] [Abstract][Full Text] [Related]
32. [The role of nuclear receptor transcription factor NR2F6 in tumor].
Huang L; Liu J; Zhu Y; Zhou Q; Xiao B; Sun Z; Li L
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2595-2602. PubMed ID: 34472280
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity.
Conte C; Moret F; Esposito D; Dal Poggetto G; Avitabile C; Ungaro F; Romanelli A; Laurienzo P; Reddi E; Quaglia F
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():876-886. PubMed ID: 31147059
[TBL] [Abstract][Full Text] [Related]
35. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
36. pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel.
Swami R; Kumar Y; Chaudhari D; Katiyar SS; Kuche K; Katare PB; Banerjee SK; Jain S
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111664. PubMed ID: 33545830
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
Kapur N; Mir H; Sonpavde GP; Jain S; Bae S; Lillard JW; Singh S
Cancer Lett; 2019 Jul; 454():1-13. PubMed ID: 30974114
[TBL] [Abstract][Full Text] [Related]
38. Activation of hypoxia-inducible factor-1α by prolonged in vivo hyperinsulinemia treatment potentiates cancerous progression in estrogen receptor-positive breast cancer cells.
Wang L; Fan J; Yan CY; Ling R; Yun J
Biochem Biophys Res Commun; 2017 Sep; 491(2):545-551. PubMed ID: 28351619
[TBL] [Abstract][Full Text] [Related]
39. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.
Doddapaneni R; Patel K; Chowdhury N; Singh M
Sci Rep; 2017 Nov; 7(1):15824. PubMed ID: 29158480
[TBL] [Abstract][Full Text] [Related]
40. Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Yardım A; Kucukler S; Özdemir S; Çomaklı S; Caglayan C; Kandemir FM; Çelik H
Gene; 2021 Feb; 769():145239. PubMed ID: 33069805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
